Changes in tumor necrosis factor-, heat shock protein 70, malondialdehyde, and superoxide dismutase in patients with different severities of alcoholic fatty liver disease

Medicine (United States)

Volumn 94, Issue 11, 2015, Pages e643-

  Qu, Bao Ge ^a,b   Wang, Hui ^a,b   Jia, Yi Guo ^a,b   Su, Ji Liang ^a,b   Wang, Zhong Dong ^a,b   Wang, Ya Fei ^a,b   Han, Xing Hai ^a,b   Liu, Yuan Xun ^a,b   Pan, Jin Dun ^a,b   Ren, Guang Ying ^a,b  

^a Department of Gastroenterology Taishan Hospital   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ULTRASOUND SCANNER; BLOOD; CASE CONTROL STUDY; INFLAMMATION; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; FATTY LIVER, ALCOHOLIC; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929668893     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000643     Document Type: Article

References (39)

1. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745-750.
2. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection fatty liver: A metaanalysis. Hepatology. 2011;54:1082-1090.
3. Nobili V, Della Corte C, Monti L, et al. The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate? Ital J Pediatr. 2011;37:36.
4. Sohail S, Aziz S, Mirza T. Ultrasound based evaluation of hepatic steatosis and fibrosis in hepatitis C non-responders. J Coll Physicians Surg Pak. 2013;23:548-552.
5. Wang HJ, Gao B, Zakhari S, et al. Inflammation in alcoholic liver disease. Annu Rev Nutr. 2012;32:343-368.
6. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 2006;65:278-290.
7. Viitala K, Makkonen K, Israel Y, et al. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcoholism: Clin Exper Res. 2000;24:1103-1109.
8. Szabo G, Petrasek J, Bala S. Innate immunity and alcoholic liver disease. Dig Dis. 2012;30:55-60.
9. González-Quintela A, Dominguez-Santalla MJ, Pérez LF, et al. Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine. 2000;12:1437-1440.
10. The Group of Chinese Medical Association Branch of Hepatology Fatty Liver and Alcoholic Liver Disease. Guidelines for diagnosis and treatment of alcoholic liver disease. Chin J Liver Dis. 2006;14:164-166.
11. Ballestri S, Lonardo A, Romagnoli D, et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int. 2012;32:1242-1252.
12. Crews FT, Bechara R, Brown LA, et al. Cytokines and alcohol. Alcohol Clin Exp Res. 2006;30:720-730.
13. Zahran WE, Salah El-Dien KA, Kamel PG, et al. Efficacy of tumor necrosis factor and interleukin-10 analysis in the follow-up of nonalcoholic fatty liver disease progression. Indian J Clin Biochem. 2013;28:141-146.
14. Laso FJ, Vaquero JM, Almeida J, et al. Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom. 2007;72:408-415.
15. Zhang Z, Bagby GJ, Stoltz D, et al. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-production in human monocytic cells. Alcohol Clin Exp Res. 2001;25:444-449.
16. Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol. 2012;27:89-93.
17. El-Taukhy MA, Salama SM, Abou-Shousha SA, et al. Effects of chronic ethanol and vitamin C administration on production of tumor necrosis factor-alpha and interleukin-6 in rats. Egypt J Immunol. 2006;13:1-10.
18. Gruden G, Barutta F, Pinach S, et al. Circulating anti-Hsp70 levels in nascent metabolic syndrome: The Casale Monferrato Study. Cell Stress Chaperones. 2013;18:353-357.
19. Njemini R, Smitz J, Demanet C, et al. Circulating heat shock protein 70 (Hsp70) in elderly members of a rural population from Cameroon: Association with infection and nutrition. Arch Gerontol Geriatr. 2011;53:359-363.
20. Njemini R, Bautmans I, Onyema OO, et al. Circulating heat shock protein 70 in health, aging and disease. BMC Immunol. 2011;12:24.
21. Ménoret A. Purification of recombinant and endogenous HSP70s. Methods. 2004;32:7-12.
22. Krepuska M, Szeberin Z, Sótonyi P, et al. Serum level of soluble Hsp70 is associated with vascular calcification. Cell Stress Chaperones. 2011;16:257-265.
23. Peraçoli JC, Bannwart-Castro CF, Romao M, et al. High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early-from late-onset preeclampsia. J Reprod Immunol. 2013;100:129-134.
24. González-Ramos M, Calleros L, López-Ongil S, et al. HSP70 increases extracellular matrix production by human vascular smooth muscle through TGF-b1 up-regulation. Int J Biochem Cell Biol. 2013;45:232-242.
25. Tarantino G, Finelli C, Colao A, et al. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med. 2012;10:50.
26. Franchi S, Sacerdote P, Moretti S, et al. The effects of alcoholism pharmacotherapy on immune responses in alcohol-dependent patients. Int J Immunopathol Pharmacol. 2010;23:847-855.
27. Gobejishvili L, Barve S, Joshi-Barve S, et al. Chronic ethanolmediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2006;291:G681-G688.
28. Jokelainen K, Parkkila S, Salaspuro M, et al. Covalent adducts of proteins with acetaldehyde in the liver as a result of acetaldehyde administration in drinking water. J Hepatol. 2000;33:926-932.
29. Niemelä O, Parkkila S, Bradford B, et al. Effect of Kupffer cell inactivation on ethanol induced protein adducts in the liver. Free Radic Biol Med. 2002;33:350-355.
30. Saito H, Ishii H. Recent understanding of immunological aspects in alcoholic hepatitis. Hepatol Res. 2004;30:193-198.
31. Pimentel-Nunes P, Roncon-Albuquerque R Jr, Gonçalves N, et al. Attenuation of toll-like receptor 2-mediated innate immune response in patients with alcoholic chronic liver disease. Liver Int. 2010;30:1003-1011.
32. Almeida J, Polvorosa MA, Gonzalez-Quintela A, et al. Decreased peripheral blood CD4/CD25 regulatory T cells in patients with alcoholic hepatitis. Alcohol Clin Exp Res. 2013;37:1361-1369.
33. Sutti S, Jindal A, Locatelli I, et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology. 2014;59:886-897.
34. Iimuro Y, Bradford BU, Yamashina S, et al. The glutathione precursor L-2-Oxothia-zolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology. 2000;31:391-398.
35. Samy W, Hassanian MA. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Arab J Gastroenterol. 2011;12:80-85.
36. Park KS, Jang BK, Kwon KM, et al. Antioxidant status in nonalcoholic steatohepatitis. Korean J Hepatol. 2005;11:135-143.
37. Sakaguchi S, Takahashi S, Sasaki T, et al. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. Drug Metab Pharmacokinet. 2011;26:30-46.
38. Galicia-Moreno M, Gutiérrez-Reyes G. The role of oxidative stress in the development of alcoholic liver disease. Rev Gastroenterol Mex. 2014;79:135-144.
39. Abdelmegeed MA, Banerjee A, Jang S, et al. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med. 2013;65:1238-1245.